Northview LifeSciences congratulates portfolio company Perimeter Medical Imaging on achieving U.S. FDA 510(k) Clearance for OCT Imaging System
March 1, 2021 – Northview LifeSciences would like to congratulate portfolio company Perimeter Medical Imaging on achieving U.S. FDA 510(k) Clearance for their OCT Imaging System. “Today’s announcement is a huge achievement for Perimeter” says Doug Janzen, past Chairman and current Board member of Perimeter Imaging. Northview was an early investor and consultant to Perimeter and are excited about being involved with bringing real time margin-visualization to U.S. clinicians during surgery.
Northview LifeSciences Advancing the Business of Science